Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Kirkpatrick

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Combinatorial Chemistry & High Throughput Screening|September 2, 1999
Structure-based drug design: combinatorial chemistry and molecular modelingD L Kirkpatrick, S Watson, S Ulhaq
Leukemia Research|November 1, 1992
Modification of the DiSC assay by the incorporation of monoclonal antibody stainingD L Kirkpatrick, L Chen, T S Goh
Leukemia Research|January 1, 1990
Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assayD L Kirkpatrick, M Duke, T S Goh
Chemico-Biological Interactions|July 29, 1998
Thioredoxin redox control of cell growth and death and the effects of inhibitorsG Powis, D L Kirkpatrick, M Angulo, et al.
Anti-Cancer Drugs|August 1, 1994
Synthesis and bioreductive potential of a mono N-oxide derivative of the alkylating agent chlorambucilD L Kirkpatrick, H L Schroeder, K J Chandler
Journal of Medicinal Chemistry|October 1, 1986
Nitrobenzyl derivatives as bioreductive alkylating agents: evidence for the reductive formation of a reactive intermediateD L Kirkpatrick, K E Johnson, A C Sartorelli
Journal of Chromatography|February 11, 1994
High-performance liquid chromatographic method for the separation of chlorambucil and its N-oxide prodrugK J Chandler, J B McCabe, D L Kirkpatrick
Oncology Research|January 1, 1994
Disulfide cytotoxicity under hypoxiaD L Kirkpatrick, I A Sa'da, W Chernoff, et al.
Die Pharmazie|October 1, 1990
Evaluation of the cytotoxicity of some Mannich bases of acetophenone against the EMT6 tumourJ R Dimmock, E Erciyas, S K Raghavan, et al.
Anti-Cancer Drug Design|February 4, 1998
Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugsM W Kunkel, D L Kirkpatrick, J I Johnson, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Combinatorial Chemistry & High Throughput Screening|September 2, 1999
Structure-based drug design: combinatorial chemistry and molecular modelingD L Kirkpatrick, S Watson, S Ulhaq
Leukemia Research|November 1, 1992
Modification of the DiSC assay by the incorporation of monoclonal antibody stainingD L Kirkpatrick, L Chen, T S Goh
Leukemia Research|January 1, 1990
Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assayD L Kirkpatrick, M Duke, T S Goh
Chemico-Biological Interactions|July 29, 1998
Thioredoxin redox control of cell growth and death and the effects of inhibitorsG Powis, D L Kirkpatrick, M Angulo, et al.
Anti-Cancer Drugs|August 1, 1994
Synthesis and bioreductive potential of a mono N-oxide derivative of the alkylating agent chlorambucilD L Kirkpatrick, H L Schroeder, K J Chandler
Journal of Medicinal Chemistry|October 1, 1986
Nitrobenzyl derivatives as bioreductive alkylating agents: evidence for the reductive formation of a reactive intermediateD L Kirkpatrick, K E Johnson, A C Sartorelli
Journal of Chromatography|February 11, 1994
High-performance liquid chromatographic method for the separation of chlorambucil and its N-oxide prodrugK J Chandler, J B McCabe, D L Kirkpatrick
Oncology Research|January 1, 1994
Disulfide cytotoxicity under hypoxiaD L Kirkpatrick, I A Sa'da, W Chernoff, et al.
Die Pharmazie|October 1, 1990
Evaluation of the cytotoxicity of some Mannich bases of acetophenone against the EMT6 tumourJ R Dimmock, E Erciyas, S K Raghavan, et al.
Anti-Cancer Drug Design|February 4, 1998
Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugsM W Kunkel, D L Kirkpatrick, J I Johnson, et al.
Pageof 5